Major drug firms expected to fare well in 2013

Published: 2013-01-09 06:59:00

Updated: 2013-01-09 06:59:00

Sales of market leaders like Dong-A Pharmaceutical, Green Cross Corp., Yuhan Corp. and Hanmi Pharmaceutical are expected to increase an average of 7.9 percent this year, according to forecasts by securities firms.

Yuhan Corp. will see a 16 percent increase in revenue this year compared to last...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK